Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

26.02.2024

1 Am J Obstet Gynecol
1 Ann Intern Med
3 Antiviral Res
4 BMJ
9 Clin Infect Dis
1 Graefes Arch Clin Exp Ophthalmol
2 Infect Control Hosp Epidemiol
3 Int J Infect Dis
1 Intensive Care Med
3 J Infect
4 J Med Virol
1 J Travel Med
2 J Virol
1 JAMA
1 Lancet
3 Lancet Infect Dis
3 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
3 Nature
1 Pol J Radiol
1 Radiology
1 Science


    Am J Obstet Gynecol

  1. BARROS FC, Gunier RB, Rego A, Sentilhes L, et al
    Maternal Vaccination Against COVID-19 and Neonatal Outcomes During Omicron: INTERCOVID-2022 Study.
    Am J Obstet Gynecol. 2024 Feb 15:S0002-9378(24)00078.
    >> Share


    Ann Intern Med


  2. Correction: SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy.
    Ann Intern Med. 2024 Feb 20. doi: 10.7326/L24-0045.
    >> Share


    Antiviral Res

  3. TAM EH, Peng Y, Yan Cheah MX, Yan C, et al
    Neutralizing antibodies to block viral entry and for identification of entry inhibitors.
    Antiviral Res. 2024 Feb 16:105834. doi: 10.1016/j.antiviral.2024.105834.
    >> Share

  4. SANTOS-FERREIRA N, Van Dycke J, Chiu W, Neyts J, et al
    Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids.
    Antiviral Res. 2024;223:105839.
    >> Share

  5. BIGOTTI MG, Klein K, Gan ES, Anastasina M, et al
    The alpha-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses.
    Antiviral Res. 2024 Feb 20:105837. doi: 10.1016/j.antiviral.2024.105837.
    >> Share


    BMJ


  6. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study.
    BMJ. 2024;384:q434.
    >> Share


  7. US workers during the covid-19 pandemic: uneven risks, inadequate protections, and predictable consequences.
    BMJ. 2024;384:q432.
    >> Share

  8. WISE J
    GMC admits error in decision over whether to investigate doctor's claims over covid vaccine.
    BMJ. 2024;384:q433.
    >> Share

  9. LEMASTERS K, Brinkley-Rubinstein L
    Covid-19 in US jails and prisons: implications for the next public health crisis.
    BMJ. 2024;384:e076975.
    >> Share


    Clin Infect Dis

  10. TOWNLEY B, Akin D, Dimaguila GL, Sawires R, et al
    Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: An ecological study.
    Clin Infect Dis. 2024 Feb 20:ciae084. doi: 10.1093.
    >> Share

  11. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    >> Share

  12. TROSEID M
    Viral, Host Factors or Both as Coronavirus Disease 2019 (COVID-19) Biomarkers.
    Clin Infect Dis. 2024 Feb 20:ciad779. doi: 10.1093.
    >> Share

  13. FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
    Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
    Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
    >> Share

  14. MONTEJANO R, Arribas JR
    COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution?
    Clin Infect Dis. 2024 Feb 17:ciae079. doi: 10.1093.
    >> Share

  15. GIACOMELLI A, Antinori S, Gori A, Cozzi-Lepri A, et al
    COVID-19: find the right questions to be answered.
    Clin Infect Dis. 2024 Feb 17:ciae078. doi: 10.1093.
    >> Share

  16. TOEPFER AP, Amarin JZ, Spieker AJ, Stewart LS, et al
    Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.
    Clin Infect Dis. 2024 Feb 15:ciae085. doi: 10.1093.
    >> Share

  17. KOMOROWSKI AS, Lo CKL, Kapoor AK, Smieja M, et al
    More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?
    Clin Infect Dis. 2024;78:324-329.
    >> Share

  18. KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
    Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
    Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
    >> Share


    Graefes Arch Clin Exp Ophthalmol

  19. CAI J, Li X, Li Q, Cai Y, et al
    Clinical characteristics of acute acquired concomitant esotropia before and after the COVID-19 pandemic: a retrospective analysis.
    Graefes Arch Clin Exp Ophthalmol. 2024 Feb 22. doi: 10.1007/s00417-024-06416.
    >> Share


    Infect Control Hosp Epidemiol

  20. WHITING KA, Guest R, Seshan VE, Kamboj M, et al
    Susceptibility of healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) hybrid immunity to XBB lineage reinfection.
    Infect Control Hosp Epidemiol. 2024 Feb 20:1-4. doi: 10.1017/ice.2023.
    >> Share

  21. BOUGES S, Jouzeau A, Lieutier-Colas F, Pefau M, et al
    Antibiotic consumption in French nursing homes between 2018 and 2022: A multicenter survey.
    Infect Control Hosp Epidemiol. 2024 Feb 19:1-6. doi: 10.1017/ice.2024.
    >> Share


    Int J Infect Dis

  22. IKEBE T, Okuno R, Uchitani Y, Yamaguchi T, et al
    Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of Group A Streptococcus isolates.
    Int J Infect Dis. 2024 Feb 19:S1201-9712(24)00022.
    >> Share

  23. BERENTSCHOT JC, Martine Bek L, Heijenbrok-Kal MH, van den Berg-Emons RJG, et al
    Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization.
    Int J Infect Dis. 2024 Feb 15:S1201-9712(24)00036.
    >> Share

  24. BIANCHI FP, Rizzi D, Daleno A, Stefanizzi P, et al
    Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
    Int J Infect Dis. 2024 Feb 14:S1201-9712(24)00028.
    >> Share


    Intensive Care Med

  25. FERNANDO SM, Brodie D, Barbaro RP, Agerstrand C, et al
    Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry.
    Intensive Care Med. 2024 Feb 20. doi: 10.1007/s00134-024-07343.
    >> Share


    J Infect

  26. ZHOU J, Lan L, Ai S, Lin J, et al
    People Living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention.
    J Infect. 2024 Feb 15:106122. doi: 10.1016/j.jinf.2024.106122.
    >> Share

  27. YAO Z, Zhang L, Duan Y, Tang X, et al
    Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.
    J Infect. 2024 Feb 15:106121. doi: 10.1016/j.jinf.2024.106121.
    >> Share

  28. HITES M, Massonnaud CR, Jamard S, Goehringer F, et al
    Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): a phase 3, randomized, double-blind, placebo-controlled trial.
    J Infect. 2024 Feb 15:106120. doi: 10.1016/j.jinf.2024.106120.
    >> Share


    J Med Virol

  29. GAN J, Zhang H, Wu J, Liu Y, et al
    Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China.
    J Med Virol. 2024;96:e29402.
    >> Share

  30. CHIRUMBOLO S, Tirelli U
    On coming back, the scaring COVID-19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS-CoV2 spreading.
    J Med Virol. 2024;96:e29490.
    >> Share

  31. OMBELET S, Castanares-Zapatero D, Desimpel F, Hulstaert F, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis.
    J Med Virol. 2024;96:e29434.
    >> Share

  32. YANG D, Chan JF, Yoon C, Luk TY, et al
    Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.
    J Med Virol. 2024;96:e29472.
    >> Share


    J Travel Med

  33. MARTINEZ-LACALZADA M, Cruz A, Subira C, Vera I, et al
    Lack of a non-specific protective effect of prior yellow fever vaccination against COVID-19.
    J Travel Med. 2024 Feb 15:taae027. doi: 10.1093.
    >> Share


    J Virol

  34. HUANG H, Lei X, Zhao C, Qin Y, et al
    Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3.
    J Virol. 2024;98:e0168223.
    >> Share

  35. STOLL GA, Nikolopoulos N, Zhai H, Zhang L, et al
    Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
    J Virol. 2024;98:e0177723.
    >> Share


    JAMA

  36. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    >> Share


    Lancet

  37. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    >> Share


    Lancet Infect Dis

  38. LI Y
    Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices - Author's reply.
    Lancet Infect Dis. 2024 Feb 15:S1473-3099(24)00082.
    >> Share

  39. FAFI I, Assad Z, Lenglart L, Valtuille Z, et al
    Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices.
    Lancet Infect Dis. 2024 Feb 15:S1473-3099(24)00081.
    >> Share

  40. PLEY C, Kampmann B
    Access to respiratory syncytial virus preventive tools for neonates and infants in Europe.
    Lancet Infect Dis. 2024 Feb 19:S1473-3099(24)00084.
    >> Share


    MMWR Morb Mortal Wkly Rep

  41. EDENS C, Clopper BR, DeVies J, Benitez A, et al
    Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:149-151.
    >> Share

  42. MUSA N, Ghoniem A, Hsu CH, Mubarak S, et al
    Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:139-144.
    >> Share

  43. FORD ND, Agedew A, Dalton AF, Singleton J, et al
    Notes from the Field: Long COVID Prevalence Among Adults - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:135-136.
    >> Share


    N Engl J Med


  44. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2024;390:772.
    >> Share

  45. BENEZECH S, Khoryati L, Belot A
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
    N Engl J Med. 2024;390:771-772.
    >> Share

  46. FRANCO A, Tremoulet A, Burns JC
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
    N Engl J Med. 2024;390:771.
    >> Share

  47. HERBERT C, McManus DD, Soni A
    Persistent False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:764-765.
    >> Share


    Nature

  48. GHAFARI M, Hall M, Golubchik T, Ayoubkhani D, et al
    Prevalence of persistent SARS-CoV-2 in a large community surveillance study.
    Nature. 2024 Feb 21. doi: 10.1038/s41586-024-07029.
    >> Share

  49. COLLINS PY, Sinha M, Concepcion T, Patton G, et al
    Making cities mental health friendly for adolescents and young adults.
    Nature. 2024 Feb 21. doi: 10.1038/s41586-023-07005.
    >> Share

  50. WONG C
    Largest post-pandemic survey finds trust in scientists is high.
    Nature. 2024;626:704.
    >> Share


    Pol J Radiol

  51. LESZCZYNSKI W, Kazimierczak W, Lemanowicz A, Serafin Z, et al
    Texture analysis of chest X-ray images for the diagnosis of COVID-19 pneumonia.
    Pol J Radiol. 2024;89:e49-e53.
    >> Share


    Radiology

  52. NECKER F, Petkov K, Engel K, Scholz M, et al
    Evolution of an Acute COVID-19 Pulmonary Infection.
    Radiology. 2024;310:e232644.
    >> Share


    Science

  53. JAYCOX JR, Dai Y, Ring AM
    Decoding the autoantibody reactome.
    Science. 2024;383:705-707.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016